Evaluation of the Interaction of Rimonabant (Antagonist of CB1 Receptor) on the Analgesic Effect of Paracetamol in Intravenous Administration.

Trial Profile

Evaluation of the Interaction of Rimonabant (Antagonist of CB1 Receptor) on the Analgesic Effect of Paracetamol in Intravenous Administration.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2011

At a glance

  • Drugs Rimonabant (Primary) ; Paracetamol
  • Indications Pain
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Jan 2011 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 18 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Sep 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top